The most common medications dispensed to lactating persons: An electronic health record‐based approach

Author:

Palmsten Kristin1ORCID,Vazquez‐Benitez Gabriela1,JaKa Meghan M.2,Bandoli Gretchen34,Ahrens Katherine A.5,Kharbanda Elyse O.1ORCID

Affiliation:

1. Pregnancy and Child Health Research Center HealthPartners Institute Minneapolis Minnesota USA

2. Center for Evaluation and Survey Research HealthPartners Institute Minneapolis Minnesota USA

3. Department of Pediatrics University of California San Diego California USA

4. Department of Family Medicine University of California San Diego California USA

5. Muskie School of Public Service University of Southern Maine Portland Maine USA

Abstract

AbstractPurposeUsing a novel, electronic health record (EHR)‐based approach, to estimate the prevalence of prescription medication use at 2, 4, and 6 months postpartum among lactating individuals.MethodsWe utilized automated EHR data from a US health system that records infant feeding information at well‐child visits. We linked mothers who received prenatal care to their infants born May 2018–June 2019, and we required infants to have ≥1 well‐child visit between 31 and 90 days of life (i.e., 2‐month well‐child visit with a ±1 month window). Mothers were classified as lactating at the 2‐month well‐child visit if their infant received breast milk at the 2‐month well‐child visit. For subsequent well‐child visits at 4 and 6 months, mothers were considered lactating if their infant was still receiving breast milk.ResultsWe identified 6013 mothers meeting inclusion criteria, and 4158 (69.2%) were classified as lactating at the 2‐month well‐child visit. Among those classified as lactating, the most common medication classes dispensed around the 2‐month well‐child visit were oral progestin contraceptives (19.1%), selective serotonin reuptake inhibitors (8.8%), first generation cephalosporins (4.3%), thyroid hormones (3.5%), nonsteroidal anti‐inflammatory agents (3.4%), penicillinase‐resistant penicillins (3.1%), topical corticosteroids (2.9%), and oral imidazole‐related antifungals (2.0%). The most common medication classes were similar around the 4 and 6‐month well‐child visits although prevalence estimates were often lower.ConclusionsProgestin‐only contraceptives, antidepressants, and antibiotics were the most dispensed medications among lactating mothers. With routine collection of breastfeeding information, mother‐infant linked EHR data may overcome limitations in previous studies of medication utilization during lactation. These data should be considered for studies of medication safety during lactation given the need for human safety data.

Funder

National Institutes of Health

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference48 articles.

1. Obstetrical, fetal, and lactation pharmacology—a crisis that can no longer be ignored

2. “Is It Safe?” — The Many Unanswered Questions about Medications and Breast-Feeding

3. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule

4. Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary

5. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling—final rule;US Food and Drug Administration, Health and Human Services;Fed Regist,2014

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mobile-Web Based Electronic Health Records System for ICU Patient Management in Heart Hospital;2023 International Conference on Ambient Intelligence, Knowledge Informatics and Industrial Electronics (AIKIIE);2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3